{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:37:23Z","timestamp":1780321043262,"version":"3.54.1"},"reference-count":128,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pulmonary hypertension (PH) is a common complication of chronic lung diseases, particularly in chronic obstructive pulmonary disease (COPD) and interstitial lung diseases (ILD) and especially in advanced disease. It is associated with greater mortality and worse clinical course. Given the high prevalence of some respiratory disorders and because lung parenchymal abnormalities might be present in other PH groups, the appropriate diagnosis of PH associated with respiratory disease represents a clinical challenge. Patients with chronic lung disease presenting symptoms that exceed those expected by the pulmonary disease should be further evaluated by echocardiography. Confirmatory right heart catheterization is indicated in candidates to surgical treatments, suspected severe PH potentially amenable with targeted therapy, and, in general, in those conditions where the result of the hemodynamic assessment will determine treatment options. The treatment of choice for these patients who are hypoxemic is long-term oxygen therapy and pulmonary rehabilitation to improve symptoms. Lung transplant is the only curative therapy and can be considered in appropriate cases. Conventional vasodilators or drugs approved for pulmonary arterial hypertension (PAH) are not recommended in patients with mild-to-moderate PH because they may impair gas exchange and their lack of efficacy shown in randomized controlled trials. Patients with severe PH (as defined by pulmonary vascular resistance &gt;5 Wood units) should be referred to a center with expertise in PH and lung diseases and ideally included in randomized controlled trials. Targeted PAH therapy might be considered in this subset of patients, with careful monitoring of gas exchange. In patients with ILD, inhaled treprostinil has been shown to improve functional ability and to delay clinical worsening.<\/jats:p>","DOI":"10.1055\/s-0043-1770121","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T22:52:57Z","timestamp":1690239177000},"page":"826-839","source":"Crossref","is-referenced-by-count":6,"title":["Management of Pulmonary Hypertension Associated with Chronic Lung Disease"],"prefix":"10.1055","volume":"44","author":[{"given":"Isabel","family":"Blanco","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic-University of Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain"},{"name":"European Reference Network on Rare Pulmonary Diseases (ERN-LUNG), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Hern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic-University of Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain"},{"name":"European Reference Network on Rare Pulmonary Diseases (ERN-LUNG), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic-University of Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain"},{"name":"European Reference Network on Rare Pulmonary Diseases (ERN-LUNG), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Torres-Castro","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic-University of Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain"},{"name":"European Reference Network on Rare Pulmonary Diseases (ERN-LUNG), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan A.","family":"Barber\u00e0","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic-University of Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain"},{"name":"European Reference Network on Rare Pulmonary Diseases (ERN-LUNG), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"M Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen pulmonary hypertension registry: survival in pulmonary hypertension subgroups","volume":"36","author":"H Gall","year":"2017","journal-title":"J Hear Lung Transplant"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"J Hurdman","year":"2013","journal-title":"Eur Respir J"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"S D Nathan","year":"2019","journal-title":"Eur Respir J"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"N Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"2101483","DOI":"10.1183\/13993003.01483-2021","article-title":"Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry","volume":"58","author":"K M Olsson","year":"2021","journal-title":"Eur Respir J"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"2100944","DOI":"10.1183\/13993003.00944-2021","article-title":"Elevated pulmonary vascular resistance predicts mortality in COPD patients","volume":"58","author":"K Zeder","year":"2021","journal-title":"Eur Respir J"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"A Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2011.11.020","article-title":"Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease","volume":"31","author":"K H Andersen","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.00107206","article-title":"Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant","volume":"30","author":"A F Shorr","year":"2007","journal-title":"Eur Respir J"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjcard.2012.09.031","article-title":"Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data","volume":"111","author":"D Dobarro","year":"2013","journal-title":"Am J Cardiol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"2002258","DOI":"10.1183\/13993003.02258-2020","article-title":"Sleep-related breathing disorders and pulmonary hypertension","volume":"57","author":"Y Adir","year":"2021","journal-title":"Eur Respir J"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"M M Hoeper","year":"2020","journal-title":"J Hear lung Transplant"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"2000041","DOI":"10.1183\/13993003.00041-2020","article-title":"Mild parenchymal lung disease and\/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension","volume":"55","author":"R A Lewis","year":"2020","journal-title":"Eur Respir J"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S2213-2600(22)00097-2","article-title":"Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis","volume":"10","author":"M M Hoeper","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1378\/chest.08-0820","article-title":"Pulmonary vascular involvement in COPD","volume":"134","author":"V I Peinado","year":"2008","journal-title":"Chest"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1183\/09031936.03.00115402","article-title":"Pulmonary hypertension in chronic obstructive pulmonary disease","volume":"21","author":"J A Barber\u00e0","year":"2003","journal-title":"Eur Respir J"},{"issue":"06","key":"ref18","first-page":"L908","article-title":"Endothelial dysfunction in pulmonary arteries of patients with mild COPD","volume":"274","author":"V I Peinado","year":"1998","journal-title":"Am J Physiol"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","article-title":"Pulmonary vascular involvement in chronic obstructive pulmonary disease. is there a pulmonary vascular phenotype?","volume":"198","author":"G Kovacs","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2021.02.012","article-title":"Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"160","author":"C D Vizza","year":"2021","journal-title":"Chest"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"2102897","DOI":"10.1183\/13993003.02897-2021","article-title":"Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort","volume":"60","author":"G Dauriat","year":"2022","journal-title":"Eur Respir J"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1378\/chest.11-2798","article-title":"Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension","volume":"142","author":"B G Boerrigter","year":"2012","journal-title":"Chest"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.arbr.2019.10.018","article-title":"Effects of pulmonary hypertension on exercise capacity in patients with chronic obstructive pulmonary disease","volume":"56","author":"I Blanco","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"issue":"160","key":"ref24","doi-asserted-by":"crossref","first-page":"200321","DOI":"10.1183\/16000617.0321-2020","article-title":"Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis","volume":"30","author":"R Torres-Castro","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"A Chaouat","year":"2008","journal-title":"Eur Respir J"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"G Thabut","year":"2005","journal-title":"Chest"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"R Kessler","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref29","first-page":"993","article-title":"Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease","volume":"130","author":"E Weitzenblum","year":"1984","journal-title":"Am Rev Respir Dis"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.chest.2022.01.031","article-title":"Severe pulmonary hypertension in copd: impact on survival and diagnostic approach","volume":"162","author":"G Kovacs","year":"2022","journal-title":"Chest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1164\/ajrccm.149.2.8306040","article-title":"Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease","volume":"149","author":"J A Barber\u00e0","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/09031936.02.00245902","article-title":"Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD","volume":"19","author":"S Santos","year":"2002","journal-title":"Eur Respir J"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.healun.2012.11.014","article-title":"Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease","volume":"32","author":"J Carlsen","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chest.2019.02.333","article-title":"Pulmonary arterial histologic lesions in patients with COPD with severe pulmonary hypertension","volume":"156","author":"V Bunel","year":"2019","journal-title":"Chest"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.201301-0162OC","article-title":"Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications","volume":"188","author":"R SJ Est\u00e9par","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201811-2063OC","article-title":"Arterial vascular pruning, right ventricular size, and clinical outcomes in chronic obstructive pulmonary disease. A longitudinal observational study","volume":"200","author":"G R Washko","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"ref37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM199105303242203","article-title":"Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease","volume":"324","author":"A T Dinh-Xuan","year":"1991","journal-title":"N Engl J Med"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1164\/ajrccm.164.4.2101023","article-title":"Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers","volume":"164","author":"J A Barber\u00e0","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"07","key":"ref39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/rccm.200605-724OC","article-title":"Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke","volume":"175","author":"S P Nana-Sinkam","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1164\/rccm.200210-1233OC","article-title":"Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease","volume":"167","author":"S Santos","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/arrd.1985.131.4.493","article-title":"Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease","volume":"131","author":"E Weitzenblum","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1164\/ajrccm\/137.6.1289","article-title":"The effects of controlled oxygen therapy on ventricular function in patients with stable and decompensated cor pulmonale","volume":"137","author":"W MacNee","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"J Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref44","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1183\/09031936.95.08091445","article-title":"More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited","volume":"8","author":"R Naeije","year":"1995","journal-title":"Eur Respir J"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"S M Arcasoy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref46","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1183\/09031936.00033007","article-title":"Estimating pulmonary artery pressures by echocardiography in patients with emphysema","volume":"30","author":"M R Fisher","year":"2007","journal-title":"Eur Respir J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"W Seeger","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.00176312","article-title":"Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial","volume":"42","author":"I Blanco","year":"2013","journal-title":"Eur Respir J"},{"issue":"17","key":"ref49","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM197204272861703","article-title":"Patterns of cardiovascular dysfunction in chronic obstructive lung disease","volume":"286","author":"B Burrows","year":"1972","journal-title":"N Engl J Med"},{"key":"ref50","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party","volume":"1","year":"1981","journal-title":"Lancet"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial","volume":"93","author":"Nocturnal Oxygen Therapy Trial Group","year":"1980","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"00348","DOI":"10.1183\/23120541.00348-2021","article-title":"Treatment of pulmonary hypertension associated with COPD: a systematic review","volume":"8","author":"R Arif","year":"2022","journal-title":"ERJ Open Res"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/CIRCHEARTFAILURE.115.002130","article-title":"Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis","volume":"8","author":"A Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1378\/chest.97.2.268","article-title":"Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease","volume":"97","author":"A GN Agust\u00ed","year":"1990","journal-title":"Chest"},{"issue":"26","key":"ref55","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198106253042606","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by nifedipine","volume":"304","author":"G Simonneau","year":"1981","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.156.3.9611051","article-title":"Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease","volume":"156","author":"N Roger","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(96)90011-2","article-title":"Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease","volume":"347","author":"J A Barber\u00e0","year":"1996","journal-title":"Lancet"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.58.4.289","article-title":"Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD","volume":"58","author":"K Vonbank","year":"2003","journal-title":"Thorax"},{"issue":"03","key":"ref59","first-page":"309","article-title":"Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis","volume":"7","author":"X Chen","year":"2015","journal-title":"J Thorac Dis"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/690017","article-title":"Chronic use of PAH-specific therapy in World Health Organization group III pulmonary hypertension: a systematic review and meta-analysis","volume":"7","author":"K W Prins","year":"2017","journal-title":"Pulm Circ"},{"issue":"08","key":"ref61","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3346\/jkms.2013.28.8.1200","article-title":"Systematic review and meta-analysis of pulmonary hypertension specific therapy for exercise capacity in chronic obstructive pulmonary disease","volume":"28","author":"J Park","year":"2013","journal-title":"J Korean Med Sci"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","article-title":"Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial","volume":"36","author":"P Vitulo","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"02","key":"ref63","first-page":"277","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","author":"W D Travis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref64","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"M Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"00272","DOI":"10.1183\/23120541.00272-2022","article-title":"Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need","volume":"8","author":"S Dhont","year":"2022","journal-title":"ERJ Open Res"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCP.0000000000000599","article-title":"Pulmonary hypertension due to interstitial lung disease","volume":"25","author":"C S King","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"04","key":"ref67","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review","volume":"46","author":"G Raghu","year":"2015","journal-title":"Eur Respir J"},{"issue":"06","key":"ref68","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000345221","article-title":"Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis","volume":"85","author":"M Kimura","year":"2013","journal-title":"Respiration"},{"issue":"05","key":"ref69","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction","volume":"46","author":"G Raghu","year":"2015","journal-title":"Eur Respir J"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0025-6196(11)61030-6","article-title":"Pulmonary hypertension in patients with interstitial lung diseases","volume":"82","author":"J H Ryu","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"C J Lettieri","year":"2006","journal-title":"Chest"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"1800545","DOI":"10.1183\/13993003.00545-2018","article-title":"Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia","volume":"52","author":"C S King","year":"2018","journal-title":"Eur Respir J"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1183\/09031936.00010414","article-title":"A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis","volume":"44","author":"R KF Oliveira","year":"2014","journal-title":"Eur Respir J"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1378\/chest.128.4.2393","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"128","author":"H F Nadrous","year":"2005","journal-title":"Chest"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","article-title":"The clinical course of patients with idiopathic pulmonary fibrosis","volume":"142","author":"F J Martinez","year":"2005","journal-title":"Ann Intern Med"},{"issue":"08","key":"ref76","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000524263","article-title":"The effect of borderline pulmonary hypertension on survival in chronic lung disease","volume":"101","author":"L Piccari","year":"2022","journal-title":"Respiration"},{"issue":"11","key":"ref77","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1164\/rccm.200308-1111OC","article-title":"Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis","volume":"169","author":"M Ebina","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000194537","article-title":"Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases","volume":"44","author":"E Weitzenblum","year":"1983","journal-title":"Respiration"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/0140-6736(93)90694-C","article-title":"Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis","volume":"341","author":"A Giaid","year":"1993","journal-title":"Lancet"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.2003.009860","article-title":"Angiogenic cytokines in patients with idiopathic interstitial pneumonia","volume":"59","author":"N R Simler","year":"2004","journal-title":"Thorax"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1430350","DOI":"10.1155\/2017\/1430350","article-title":"Pulmonary hypertension associated with idiopathic pulmonary fibrosis: current and future perspectives","volume":"2017","author":"S D Collum","year":"2017","journal-title":"Can Respir J"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4049\/jimmunol.1303255","article-title":"GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice","volume":"193","author":"A Shiomi","year":"2014","journal-title":"J Immunol"},{"issue":"02","key":"ref83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm\/143.2.219","article-title":"Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis","volume":"143","author":"A GN Agust\u00ed","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00063198-200303000-00007","article-title":"Pathophysiology of pulmonary hypertension due to lung disease","volume":"9","author":"K W Presberg","year":"2003","journal-title":"Curr Opin Pulm Med"},{"issue":"03","key":"ref85","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000114246","article-title":"Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"76","author":"S D Nathan","year":"2008","journal-title":"Respiration"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"H Nunes","year":"2006","journal-title":"Thorax"},{"issue":"166","key":"ref87","doi-asserted-by":"crossref","first-page":"220091","DOI":"10.1183\/16000617.0091-2022","article-title":"Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties","volume":"31","author":"J MJ Lemmers","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"1702596","DOI":"10.1183\/13993003.02596-2017","article-title":"The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"51","author":"V Cottin","year":"2018","journal-title":"Eur Respir J"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chest.2022.02.012","article-title":"Screening strategies for pulmonary hypertension in patients with interstitial lung disease: a multidisciplinary Delphi study","volume":"162","author":"F F Rahaghi","year":"2022","journal-title":"Chest"},{"issue":"05","key":"ref90","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1378\/chest.126.5.1460","article-title":"Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure","volume":"126","author":"M Bonay","year":"2004","journal-title":"Chest"},{"issue":"09","key":"ref91","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"S D Nathan","year":"2008","journal-title":"Respir Med"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2466-14-194","article-title":"Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases","volume":"14","author":"S Aliberti","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"05","key":"ref93","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1378\/chest.87.5.558","article-title":"Pulmonary hypertension in the interstitial lung diseases","volume":"87","author":"J I Kennedy","year":"1985","journal-title":"Chest"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial","volume":"360","author":"H A Ghofrani","year":"2002","journal-title":"Lancet"},{"issue":"02","key":"ref95","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.160.2.9810008","article-title":"Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis","volume":"160","author":"H Olschewski","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1152\/japplphysiol.01104.2010","article-title":"Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis","volume":"110","author":"I Blanco","year":"2011","journal-title":"J Appl Physiol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12916-016-0558-x","article-title":"Treatment of idiopathic pulmonary fibrosis: a network meta-analysis","volume":"14","author":"B Rochwerg","year":"2016","journal-title":"BMC Med"},{"issue":"09","key":"ref98","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","volume":"7","author":"S D Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"992879","DOI":"10.3389\/fcvm.2022.992879","article-title":"PAH-specific therapy for pulmonary hypertension and interstitial lung disease: a systemic review and meta-analysis","volume":"9","author":"N Zhao","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"04","key":"ref100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"A Waxman","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"ref101","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S2213-2600(21)00165-X","article-title":"Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study","volume":"9","author":"S D Nathan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.prostaglandins.2015.04.007","article-title":"The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: role of membrane versus nuclear receptors","volume":"120","author":"L H Clapp","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"04","key":"ref103","first-page":"382","article-title":"Role of prostacyclin in pulmonary hypertension","volume":"2014","author":"J A Mitchell","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"issue":"09","key":"ref104","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1007\/s12325-022-02229-8","article-title":"The antifibrotic effects of inhaled treprostinil: an emerging option for ILD","volume":"39","author":"M Kolb","year":"2022","journal-title":"Adv Ther"},{"issue":"02","key":"ref105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/rccm.202107-1766OC","article-title":"Efficacy of inhaled treprostinil on multiple disease progression events in patients with pulmonary hypertension due to parenchymal lung disease in the INCREASE Trial","volume":"205","author":"S D Nathan","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"ref106","first-page":"2133","article-title":"Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension","volume":"60","author":"S Nathan","year":"2022","journal-title":"Eur Respir J"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"V Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1378\/chest.09-2962","article-title":"Tobacco smoke: a risk factor for pulmonary arterial hypertension? A case-control study","volume":"138","author":"R Schiess","year":"2010","journal-title":"Chest"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"V Cottin","year":"2010","journal-title":"Eur Respir J"},{"key":"ref110","first-page":"148","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"57","author":"S D Nathan","year":"2012","journal-title":"Eur Respir Monogr"},{"issue":"06","key":"ref111","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/his.13153","article-title":"Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone","volume":"70","author":"N Awano","year":"2017","journal-title":"Histopathology"},{"issue":"01","key":"ref112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1378\/chest.08-2306","article-title":"Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension","volume":"136","author":"M Mej\u00eda","year":"2009","journal-title":"Chest"},{"issue":"06","key":"ref113","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/resp.13231","article-title":"Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema","volume":"23","author":"J Jacob","year":"2018","journal-title":"Respirology"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"1700379","DOI":"10.1183\/13993003.00379-2017","article-title":"Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis","volume":"50","author":"J Jacob","year":"2017","journal-title":"Eur Respir J"},{"issue":"04","key":"ref115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"V Cottin","year":"2005","journal-title":"Eur Respir J"},{"issue":"03","key":"ref116","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1183\/09031936.00105110","article-title":"Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig","volume":"38","author":"E Ferrer","year":"2011","journal-title":"Eur Respir J"},{"issue":"12","key":"ref117","doi-asserted-by":"crossref","first-page":"e0141911","DOI":"10.1371\/journal.pone.0141911","article-title":"Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias","volume":"10","author":"M M Hoeper","year":"2015","journal-title":"PLoS One"},{"issue":"05","key":"ref118","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/resp.12294","article-title":"Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors","volume":"19","author":"G S Zimmermann","year":"2014","journal-title":"Respirology"},{"issue":"06","key":"ref119","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.healun.2021.02.006","article-title":"Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study","volume":"40","author":"S D Nathan","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"04","key":"ref120","doi-asserted-by":"crossref","first-page":"1700465","DOI":"10.1183\/13993003.00465-2017","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"A Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"107008","DOI":"10.1016\/j.rmed.2022.107008","article-title":"Predictors of lung transplant waitlist mortality for sarcoidosis","volume":"205","author":"R Gupta","year":"2022","journal-title":"Respir Med"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.mcna.2010.02.009","article-title":"Sleep in congestive heart failure","volume":"94","author":"B Sharma","year":"2010","journal-title":"Med Clin North Am"},{"issue":"01","key":"ref123","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.11-3241","article-title":"Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis","volume":"144","author":"A D Poms","year":"2013","journal-title":"Chest"},{"issue":"01","key":"ref124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000452957","article-title":"Precapillary pulmonary hypertension and sleep-disordered breathing: is there a link?","volume":"93","author":"R Thurnheer","year":"2017","journal-title":"Respiration"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/679995","article-title":"Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology","volume":"5","author":"C Kholdani","year":"2015","journal-title":"Pulm Circ"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00147712","article-title":"Functional impact of pulmonary hypertension due to hypoventilation and changes under noninvasive ventilation","volume":"43","author":"M Held","year":"2014","journal-title":"Eur Respir J"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00000658-198805000-00015","article-title":"Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss","volume":"207","author":"H J Sugerman","year":"1988","journal-title":"Ann Surg"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"107935","DOI":"10.1016\/j.pharmthera.2021.107935","article-title":"Sleep apnea and pulmonary hypertension: a riddle waiting to be solved","volume":"227","author":"S Sharma","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"10","key":"ref129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/eurheartj\/eht540","article-title":"Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial","volume":"36","author":"S Ulrich","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1770121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T23:47:32Z","timestamp":1698709652000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1770121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":128,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2023,10,30]]},"published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1770121","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}